Shire acquisition to give Takeda new global footprint

With an agreement to acquire Shire plc (LSE:SHP; NASDAQ:SHPG) now in hand, Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) is poised to expand its U.S. presence through the creation of a combined company that makes good on President and CEO Christophe Weber’s mandate to create a global biopharma company.

The deal would create a company that would derive 48% of its revenues from the U.S. and 19% from the pharma’s home country of Japan...